What medications are used in palliative medicine for symptom management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Symptom Management in Palliative Medicine

The cornerstone medications for palliative symptom management include opioids (particularly morphine as first-line), benzodiazepines (midazolam), antipsychotics (levomepromazine, chlorpromazine), and adjuvant medications tailored to specific symptoms. 1, 2

Pain Management

WHO Analgesic Ladder Approach

The World Health Organization (WHO) analgesic ladder provides a systematic approach to pain management:

  1. Mild Pain (1-3/10)

    • Acetaminophen and/or NSAIDs
  2. Moderate Pain (4-6/10)

    • Weak opioids (codeine, dihydrocodeine) plus acetaminophen/NSAIDs
    • Adjuvant medications as needed
  3. Severe Pain (7-10/10)

    • Strong opioids plus acetaminophen/NSAIDs
    • Adjuvant medications as needed 1

Strong Opioids for Pain

  • Morphine: First-line strong opioid of choice 1, 2
  • Other strong opioids: Diamorphine, buprenorphine, hydromorphone, fentanyl, oxycodone, methadone 1
  • Administration: Regular around-the-clock dosing with breakthrough dosing (typically 1/6 of daily requirement) 1, 3
  • Conversion: When changing between opioids, use established conversion tables (e.g., 10mg parenteral morphine = 30mg oral morphine) 4, 5

Adjuvant Analgesics

  • Neuropathic pain: Anticonvulsants (e.g., pregabalin)
  • Bone pain: Bisphosphonates
  • Very-low-dose methadone: Can help prevent opioid hyperalgesia when used with other opioids 6

Dyspnea Management

  • Opioids: First-line for unrelieved dyspnea
  • Benzodiazepines: When dyspnea is associated with anxiety
  • Oxygen therapy: For hypoxemic patients 2

Delirium Management

  • First-line: Antipsychotics
    • Levomepromazine: 12.5-25mg starting dose, up to 300mg/day continuous infusion
    • Chlorpromazine: 12.5mg IV/IM every 4-12h or 25-100mg rectally every 4-12h 1, 2

Important: Opioids or benzodiazepines as initial treatment can worsen delirium 1, 2

Sleep Disturbances

  • Insomnia medications:

    • Trazodone: 25-100mg PO at bedtime
    • Olanzapine: 2.5-5mg PO at bedtime
    • Zolpidem: 5mg PO at bedtime
    • Mirtazapine: 7.5-30mg PO at bedtime
    • Chlorpromazine: 25-50mg PO at bedtime
    • Quetiapine: 2.5-5mg PO at bedtime
    • Lorazepam: 0.5-1mg PO at bedtime 1
  • Daytime sedation management:

    • Caffeine: 100-200mg PO q6h (last dose by 4 PM)
    • Methylphenidate: 2.5-20mg PO BID
    • Dextroamphetamine: 2.5-10mg PO BID
    • Modafinil: 100-400mg PO each morning 1

Palliative Sedation for Refractory Symptoms

Medications for Palliative Sedation

  • Benzodiazepines:

    • Midazolam: First-line, 0.5-1mg/h starting dose, 1-20mg/h usual effective dose 1, 2
  • Neuroleptics/Antipsychotics:

    • Levomepromazine: 12.5-25mg starting dose, especially for delirium 1
    • Chlorpromazine: 12.5mg IV/IM every 4-12h 1
  • Barbiturates and anesthetic agents (for refractory cases):

    • Phenobarbital: 1-3mg/kg SC/IV bolus, followed by 0.5mg/kg/h infusion
    • Propofol: 20mg loading dose, followed by 50-70mg/h infusion 1

End-of-Life "Anticipatory" Medications

The "4 A's" approach ensures medications are available for common end-of-life symptoms:

  • Analgesic: For pain (morphine)
  • Anti-emetic: For nausea/vomiting
  • Anxiolytic: For anxiety (midazolam)
  • Anti-secretory: For respiratory secretions 5

Important Prescribing Considerations

  • Route of administration: Adapt to patient's condition (oral → subcutaneous → intravenous)
  • Breakthrough medication: Always prescribe alongside regular medications
  • Pre-existing medications: Continue pain medications unless adverse effects occur 1, 2
  • Dose titration: Titrate based on symptom response and breakthrough medication requirements 1, 4

Common Pitfalls to Avoid

  • Inadequate pain assessment: Use validated tools (visual analog scales, numerical rating scales)
  • Delayed escalation: Don't delay moving up the analgesic ladder when pain is inadequately controlled
  • Inappropriate opioid reduction: Don't reduce opioids solely for decreased vital signs when necessary for symptom control
  • Neglecting breakthrough dosing: Always provide for breakthrough symptoms alongside regular medications
  • Forgetting adjuvant medications: Use acetaminophen/NSAIDs at all steps of the analgesic ladder 1, 2, 5
  • Mismanaging delirium: Don't use opioids or benzodiazepines as first-line for delirium 1, 2

High-dose morphine use in palliative care has been shown to be safe and does not adversely affect patients' life expectancy when properly titrated for symptom control 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.